PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nettis and colleagues conducted a four-week randomized controlled trial of minocycline added to ongoing antidepressant treatment in 70 patients with treatment-resistant depression and elevated CRP, finding significant reductions in depressive symptoms compared to placebo, with effect size increasing across tertiles of baseline inflammation [65].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Astrocyte barriers to neurotoxic inflammation
Sofroniew, M. V. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3898 · Cited by 1,202 · cited 1×
“Similarly, astrocytes exhibit dynamic functional changes during neuroinflammation, interacting with microglia to regulate synaptic transmission, BBB integrity, and neurotrophic support [6, 7].”
Social stress induces neurovascular pathology promoting depression
Menard, C., Pfau, M. L., Hodes, G. E., Kana, V., Wang, V. X., Bouchard, S., Takahashi, A., Flanigan, M. E., Aleyasin, H., LeClair, K. B., et al. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0010-3 · Cited by 1,028
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930 · cited 8×
“To our knowledge, the most compelling preliminary evidence linking OCD with neuroinflammation comes from a recent TSPO PET imaging study using the second-generation tracer[ 18 F]FEPPA [98].”
InfluentialPassos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P. V., Kapczinski, F., & Kauer-Sant'Anna, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00309-0 · Cited by 743 · cited 1×
“While the immune-inflammatory hypothesis of PTSD is supported by peripheral biomarker studies (e.g., elevated IL-1β, IL-6, and TNF-α in blood) [104–106], TSPO PET imaging reveals distinct neuroimmune dynamics.”
Functional diversity of astrocytes in neural circuit regulation
Haim, L. B., & Rowitch, D. H. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.159 · Cited by 618
Enache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615
Risk factors for suicidality in Europe: Results from the ESEMED study
Bernal, M., Haro, J. M., Bernert, S., Brugha, T., de Graaf, R., Bruffaerts, R., Lépine, J. P., de Girolamo, G., Vilagut, G., Gasquet, I., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.09.018 · Cited by 565 · cited 1×
“The prevalence is notably high among high-risk occupations (e.g., veterans and healthcare workers), contributing to significant social dysfunction and economic burden [102, 103].”
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.003 · Cited by 524 · cited 1×
“This dysfunction is potentially associated with several neurodegenerative diseases such as Parkinson’s disease (PD), Huntington’s disease (HD), and Alzheimer’s disease (AD) [31–33], as well as various psychiatric disorders and stress-related conditions, including bipolar disorder and MDD [34, 35].”
Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains
Ye, X., Sun, X., Starovoytov, V., & Cai, Q. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv056 · Cited by 274 · cited 1×
“This dysfunction is potentially associated with several neurodegenerative diseases such as Parkinson’s disease (PD), Huntington’s disease (HD), and Alzheimer’s disease (AD) [31–33], as well as various psychiatric disorders and stress-related conditions, including bipolar disorder and MDD [34, 35].”
Research works printed but not linked: 126
- Zhang L, Hu K, Shao T, Hou L, Zhang S, Ye W et al (2021) Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Acta Pharm Sin B 11:373–393 · DOI · Paper page
- Beurel E, Toups M, Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107:234–256 · DOI · Paper page
- Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119–145 · DOI · Paper page
- Boche D, Perry VH, Nicoll JAR (2013) Review: Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39:3–18 · DOI · Paper page
- Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S et al (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063–3070 · DOI · Paper page
- Galea I (2021) The blood–brain barrier in systemic infection and inflammation. Cell Mol Immunol 18:2489–2501 · DOI · Paper page
- Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E (2018) TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun 69:556–567 · DOI · Paper page
- Kamintsky L, Cairns KA, Veksler R, Bowen C, Beyea SD, Friedman A et al (2020) Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression. Neuroimage Clin; 26. · DOI
- Medina-Rodriguez EM, Beurel E (2022) Blood brain barrier and inflammation in depression. Neurobiol Dis; 175 · DOI · Paper page
- Meyer JH, Cervenka S, Kim M-J, Kreisl WC, Henter ID, Innis RB (2020) Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry 7:1064–1074 · DOI · Paper page
- Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère J-J, Lindemann P et al (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402–409 · DOI · Paper page
- Attwells S, Setiawan E, Rusjan PM, Xu C, Hutton C, Rafiei D et al (2020) Translocator protein distribution volume predicts reduction of symptoms during open-label trial of celecoxib in major depressive disorder. Biol Psychiatry 88:649–656 · DOI
- Papadopoulos V, Liu J, Culty M (2007) Is there a mitochondrial signaling complex facilitating cholesterol import? Mol Cell Endocrinol 265–266:59–64 · DOI
- Papadopoulos V (2014) On the role of the translocator protein (18-kDa) TSPO in steroid hormone biosynthesis. Endocrinology 155:15–20 · DOI · Paper page
- Miller WL (2013) Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol 379:62–73 · DOI · Paper page
- Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V (2014) Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155:89–97 · DOI · Paper page
- Levin E, Premkumar A, Veenman L, Kugler W, Leschiner S, Spanier I et al (2005) The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry 44:9924–9935 · DOI
- Kletsas D, Li W, Han Z, Papadopoulos V (2004) Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem Pharmacol 67:1927–1932 · DOI
- Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V (2007) Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Biochem Pharmacol 73:491–503 · DOI
- Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M (2009) CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 48:4652–4661 · DOI · Paper page
- Gavish M, Veenman L (2018) Regulation of mitochondrial, cellular, and organismal functions by TSPO. In: Apprentices to genius: a tribute to Solomon H. Snyder p103–36 · DOI
- Gatliff J, Campanella M (2015) TSPO is a REDOX regulator of cell mitophagy. Biochem Soc Trans 43:543–552 · DOI
- Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Liévens JC (2015) PINK1-induced mitophagy promotes neuroprotection in Huntington’s disease. Cell Death Dis 6:e1617 · DOI · Paper page
- Klinedinst NJ, Regenold WT (2014) A mitochondrial bioenergetic basis of depression. J Bioenerg Biomembr 47:155–171 · DOI
- Kuffner K, Triebelhorn J, Meindl K, Benner C, Manook A, Sudria-Lopez D et al (2018) Major depressive disorder is associated with impaired mitochondrial function in skin fibroblasts. Cells 9 · DOI
- Ransohoff RM, Schafer D, Vincent A, Blachère NE, Bar-Or A (2015) Neuroinflammation: ways in which the immune system affects the brain. Neurotherapeutics 12:896–909 · DOI · Paper page
- Qin L, Xiao L, Zhu H, Du Y, Tang Y, Feng L (2024) Translocator protein (18 kDa) positron emission tomography imaging as a biomarker of neuroinflammation in epilepsy. Neurol Sci 45:5201–5211 · DOI
- Maeng SH, Hong H (2019) Inflammation as the potential basis in depression. Int Neurourol J 23:S63-71 · DOI
- Lavisse S, Guillermier M, Hérard A-S, Petit F, Delahaye M, Van Camp N et al (2012) Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci 32:10809–10818 · DOI · Paper page
- Rupprecht R, Wetzel CH, Dorostkar M, Herms J, Albert NL, Schwarzbach J et al (2022) Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders? Mol Psychiatry 27:2918–2926 · DOI
- Chauveau F, Boutin H, Van Camp N, Dollé F, Tavitian B (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35:2304–2319 · DOI · Paper page
- Dollé F, Luus C, Reynolds A, Kassiou M (2009) Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. Curr Med Chem 16:2899–2923 · DOI · Paper page
- Tang D, McKinley ET, Hight MR, Uddin MI, Harp JM, Fu A et al (2013) Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging. J Med Chem 56:3429–3433 · DOI
- Scarf AM, Ittner LM, Kassiou M (2009) The translocator protein (18 kDa): central nervous system disease and drug design. J Med Chem 52:581–592 · DOI · Paper page
- Imaizumi M, Kim HJ, Zoghbi SS, Briard E, Hong J, Musachio JL et al (2007) PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett 411:200–205 · DOI · Paper page
- Zhang MR, Kida T, Noguchi J, Furutsuka K, Maeda J, Suhara T et al (2003) [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol 30:513–519 · DOI · Paper page
- Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S et al (2017) 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58:320–325 · DOI · Paper page
- Fan Z, Calsolaro V, Atkinson RA, Femminella GD, Waldman A, Buckley C et al (2016) Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein. J Nucl Med 57:1753–1759 · DOI · Paper page
- Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L et al (2018) Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry 5:339–347 · DOI · Paper page
- James ML, Selleri S, Kassiou M (2006) Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem 13:1991–2001 · DOI · Paper page
- Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442 · DOI · Paper page
- Afridi R, Suk K (2021) Neuroinflammatory basis of depression: learning from experimental models. Front Cell Neurosci 15 · DOI · Paper page
- Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED et al (2018) PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. EJNMMI Res 8 · DOI · Paper page
- Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G et al (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72 · DOI · Paper page
- Li H, Sagar AP, Kéri S (2018) Translocator protein (18 kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 83:1–7 · DOI
- Li H, Sagar AP, Kéri S (2018) Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder. J Affect Disord 241:305–310 · DOI · Paper page
- Holmes SE, Hinz R, Conen S, Gregory CJ, Matthews JC, Anton-Rodriguez JM et al (2018) Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry 83:61–69 · DOI · Paper page
- Su L, Faluyi YO, Hong YT, Fryer TD, Mak E, Gabel S et al (2016) Neuroinflammatory and morphological changes in late-life depression: the NIMROD study. Br J Psychiatry 209:525–526 · DOI · Paper page
- Joo Y-H, Lee M-W, Son Y-D, Chang K-A, Yaqub M, Kim H-K et al (2021) In vivo cerebral translocator protein (TSPO) binding and its relationship with blood adiponectin levels in treatment-naïve young adults with major depression: a [11C]PK11195 PET study. Bio 10 · DOI
- Schubert JJ, Veronese M, Fryer TD, Manavaki R, Kitzbichler MG, Nettis MA et al (2021) A modest increase in 11C-PK11195-positron emission tomography TSPO binding in depression is not associated with serum C-reactive protein or body mass index. Biol Psychiatry Cogn Neurosci Neuroimaging 6:716–724
- Gędek A, Szular Z, Antosik AZ, Mierzejewski P, Dominiak M (2023) Celecoxib for mood disorders: a systematic review and meta-analysis of randomized controlled trials. J Clin Med 12 · DOI
- Zazula R, Husain MI, Mohebbi M, Walker AJ, Chaudhry IB, Khoso AB et al (2020) Minocycline as adjunctive treatment for major depressive disorder: pooled data from two randomized controlled trials. Aust N Z J Psychiatry 55:784–798 · DOI · Paper page
- Riebel M, Brunner L-M, Nothdurfter C, Wein S, Schwarzbach J, Liere P et al (2024) Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression. Eur Arch Psychiatry Clin Neurosci · DOI
- Bhandage AK, Jin Z, Korol SV, Shen Q, Pei Y, Deng Q et al (2018) GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4+ T cells and is immunosuppressive in type 1 diabetes. EBioMedicine 30:283–294 · DOI · Paper page
- Kim JK, Kim YS, Lee H-M, Jin HS, Neupane C, Kim S et al (2018) GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat Commun 9 · DOI · Paper page
- Tovar-Gudiño E, Guevara-Salazar JA, Bahena-Herrera JR, Trujillo-Ferrara JG, Martínez-Campos Z, Razo-Hernández RS et al (2018) Novel-substituted heterocyclic GABA analogues. Enzymatic activity against the GABA-AT enzyme from Pseudomonas fluorescens and in silico molecular modeling. Molecules 23 · DOI
- Bannister E (2019) There is increasing evidence to suggest that brain inflammation could play a key role in the aetiology of psychiatric illness. Could inflammation be a cause of the premenstrual syndromes PMS and PMDD? Post Reprod Health 25:157–61 · DOI
- Bäckström T, Doverskog M, Blackburn TP, Scharschmidt BF, Felipo V (2024) Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment. Neurosci Biobehav Rev 161 · DOI
- Coirini H, Rey M (2015) Synthetic neurosteroids on brain protection. Neural Regen Res 10 · DOI
- Eser D, Romeo E, Baghai TC, Schüle C, Zwanzger P, Rupprecht R (2006) Neuroactive steroids as modulators of depression and anxiety. Expert Rev Endocrinol Metab 1:517–526 · DOI
- Zorumski CF, Paul SM, Izumi Y, Covey DF, Mennerick S (2013) Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev 37:109–122 · DOI · Paper page
- Meshkat S, Teopiz KM, Di Vincenzo JD, Bailey JB, Rosenblat JD, Ho RC et al (2023) Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder. J Affect Disord 340:893–898 · DOI
- Barron AM, Higuchi M, Hattori S, Kito S, Suhara T, Ji B (2020) Regulation of anxiety and depression by mitochondrial translocator protein-mediated steroidogenesis: the role of neurons. Mol Neurobiol 58:550–563 · DOI
- Ren P, Ma L, Wang J-Y, Guo H, Sun L, Gao M-L et al (2020) Anxiolytic and anti-depressive like effects of translocator protein (18 kDa) ligand YL-IPA08 in a rat model of postpartum depression. Neurochem Res 45:1746–1757 · DOI
- Nozaki K, Ito H, Ohgidani M, Yamawaki Y, Sahin EH, Kitajima T et al (2020) Antidepressant effect of the translocator protein antagonist ONO-2952 on mouse behaviors under chronic social defeat stress. Neuropharmacology 162 · DOI
- Dean SL, Singer HS (2017) Treatment of Sydenham’s chorea: a review of the current evidence. Tremor Other Hyperkinet Mov (N Y) 7:456 · DOI
- Meyer J (2021) Inflammation, obsessive-compulsive disorder, and related disorders. In: The neurobiology and treatment of OCD: accelerating progress. Chap 210:p31–53 · DOI
- Alonso P, López-Solà C, Real E, Segalàs C, Menchón JM (2015) Animal models of obsessive-compulsive disorder: utility and limitations. Neuropsychiatr Dis Treat 11:1939–1955 · DOI
- Grados M, Prazak M, Saif A, Halls A (2015) A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models. Expert Opin Drug Discov 11:27–43 · DOI
- Leone D, Gilardi D, Corrò BE, Menichetti J, Vegni E, Correale C et al (2019) Psychological characteristics of inflammatory bowel disease patients: a comparison between active and nonactive patients. Inflamm Bowel Dis 25:1399–1407 · DOI · Paper page
- Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A et al (2011) The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 14:606–617 · DOI · Paper page
- Pittenger C, Adams TG Jr, Gallezot JD, Crowley MJ, Nabulsi N, James R et al (2016) OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. J Affect Disord 196:87–96 · DOI · Paper page
- Akkus F, Terbeck S, Ametamey SM, Rufer M, Treyer V, Burger C et al (2014) Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 17:1915–1922 · DOI · Paper page
- Wong DF, Brasić JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y et al (2008) Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33:1239–1251 · DOI · Paper page
- Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y et al (2010) Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. Neuroimage 49:121–126 · DOI · Paper page
- Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S et al (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007:65704 · DOI · Paper page
- Cosco TD, Pillinger T, Emam H, Solmi M, Budhdeo S, Matthew Prina A et al (2019) Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Mol Neurobiol 56:4751–4759 · DOI
- Kumar A, Williams MT, Chugani HT (2015) Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK11195. J Child Neurol 30:749–756 · DOI · Paper page
- Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L et al (2017) Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psy 74 · DOI · Paper page
- Garabadu D, Kumar V (2019) Celecoxib potentiates the antianxiety and anticompulsive-like activity of fluoxetine against chronic unpredictable mild stress in experimental animals. Behav Pharmacol 30:251–259 · DOI
- Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci CC et al (2023) Minocycline as treatment for psychiatric and neurological conditions: a systematic review and meta-analysis. Int J Mol Sci 24 · DOI
- Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH et al (2017) Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 78:e766–e773 · DOI · Paper page
- von der Warth R, Dams J, Grochtdreis T, König HH (2020) Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review. Eur J Psychotraumatol 11:1753940 · DOI · Paper page
- Sun Y, Qu Y, Zhu J (2021) The relationship between inflammation and post-traumatic stress disorder. Front Psychiatry 12 · DOI
- Zuo C, Zhuang Z, Yang P, Zhang H, Li X, Huang T et al (2023) Dissecting the causal association between inflammation and post-traumatic stress disorder: a bidirectional Mendelian randomization study. J Affect Disord 333:436–445 · DOI
- Smith KL, Kassem MS, Clarke DJ, Kuligowski MP, Bedoya-Pérez MA, Todd SM et al (2019) Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD. Brain Behav Immun 80:889–899 · DOI · Paper page
- Chaaya N, Wang J, Jacques A, Beecher K, Chaaya M, Battle AR et al (2021) Contextual fear memory maintenance changes expression of pMAPK, BDNF and IBA-1 in the pre-limbic cortex in a layer-specific manner. Front Neural Circuits 15:660199 · DOI
- Kao CY, He Z, Zannas AS, Hahn O, Kühne C, Reichel JM et al (2016) Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. J Psychiatr Res 76:74–83 · DOI
- Bhatt S, Hillmer AT, Girgenti MJ, Rusowicz A, Kapinos M, Nabulsi N et al (2020) PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies. Nat Commun 11 · DOI
- Bonomi R, Hillmer AT, Woodcock E, Bhatt S, Rusowicz A, Angarita GA et al (2024) Microglia-mediated neuroimmune suppression in PTSD is associated with anhedonia. Proc Natl Acad Sci U S A 121:e2406005121 · DOI
- Deri Y, Clouston SAP, DeLorenzo C, Gardus JD, Bartlett EA, Santiago-Michels S et al (2021) Neuroinflammation in World Trade Center responders at midlife: a pilot study using [18F]-FEPPA PET imaging. Brain Behav Immun Health 16 · DOI
- Seo S, Jung YH, Lee D, Lee WJ, Jang JH, Lee JY et al (2021) Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET. PLoS ONE 16:e0246152 · DOI · Paper page
- Watling SE, Gill T, Gaudette EV, Richardson JD, McCluskey T, Tong J et al (2023) Investigating TSPO levels in occupation-related posttraumatic stress disorder. Sci Rep 13 · DOI
- Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH (2016) Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J Physiol Pharmacol 20:357–366 · DOI · Paper page
- Patankar PS, Joshi S, Mane A, Manjesh PS, Kokate D (2021) Anxiolytic effect of minocycline in posttraumatic stress disorder model of Syrian hamsters. Tzu Chi Med J 33:263–269 · DOI
- Qiu ZK, Zhang LM, Zhao N, Chen HX, Zhang YZ, Liu YQ et al (2013) Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 45:40–46 · DOI
- Shang C, Guo Y, Yao JQ, Fang XX, Sun LJ, Jiang XY et al (2020) Rapid anti-PTSD-like activity of the TSPO agonist YL-IPA08: emphasis on brain GABA, neurosteroids and HPA axis function. Behav Brain Res 379:112320 · DOI
- Qiu Z-K, Liu X, Chen Y, Wu R-J, Guan S-F, Pan Y-y et al (2020) Translocator protein 18 kDa: a potential therapeutic biomarker for post traumatic stress disorder. Metab Brain Dis 35:695–707 · DOI
- Lv H, Guo M, Guo C, He K (2024) The interrelationships between cytokines and schizophrenia: a systematic review. Int J Mol Sci 25 · doi:10.37766/inplasy2024.7.0128
- Williams JA, Burgess S, Suckling J, Lalousis PA, Batool F, Griffiths SL et al (2022) Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study. JAMA Psychiat 79:498–507 · DOI · Paper page
- Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M et al (2018) Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry 23:323–334 · DOI · Paper page
- Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al (2015) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull 41:85–93 · DOI · Paper page
- Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A et al (2017) Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [(11)C]PBR28. Mol Psychiatry 22:850–856 · DOI · Paper page
- Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M et al (2020) Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Transl Psychiatry 10:94 · DOI
- De Picker L, Ottoy J, Verhaeghe J, Deleye S, wyffels L, Fransen E et al (2019) State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: evidence for the accelerated ageing hypothesis? Brain Behav Immun 77:46–54 · DOI
- Ottoy J, De Picker L, Verhaeghe J, Deleye S, wyffels L, Kosten L et al (2018) 18F-PBR111 PET imaging in healthy controls and schizophrenia: test–retest reproducibility and quantification of neuroinflammation. J Nucl Med 59:1267–74 · DOI
- Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR et al (2016) Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C]PBR28 PET brain imaging study. Am J Psychiatry 173:44–52 · DOI · Paper page
- Hafizi S, Tseng H-H, Rao N, Selvanathan T, Kenk M, Bazinet RP et al (2017) Imaging microglial activation in untreated first-episode psychosis: a PET study with [18F]FEPPA. Am J Psychiatry 174:118–124 · DOI · Paper page
- Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M et al (2016) In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry 6:e777 · DOI · Paper page
- Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G et al (2018) Interaction between TSPO—a neuroimmune marker—and redox status in clinical high risk for psychosis: a PET–MRS study. Neuropsychopharmacology 43:1700–1705 · DOI
- Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al (2014) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull 41:85–93 · DOI · Paper page
- Hafizi S, Da Silva T, Gerritsen C, Kiang M, Bagby RM, Prce I et al (2017) Imaging microglial activation in individuals at clinical high risk for psychosis: an in vivo PET study with [(18)F]FEPPA. Neuropsychopharmacology 42:2474–2481 · DOI
- Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50:1801–1807 · DOI · Paper page
- Banati R, Hickie IB (2009) Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Med J Aust 190:S26-32 · DOI · Paper page
- van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E et al (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64:820–822 · DOI · Paper page
- Conen S, Gregory CJ, Hinz R, Smallman R, Corsi-Zuelli F, Deakin B et al (2021) Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis. Mol Psychiatry 26:5398–5406 · DOI
- Takano A, Arakawa R, Ito H, Tateno A, Takahashi H, Matsumoto R et al (2010) Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. Int J Neuropsychopharmacol 13:943–950 · DOI · Paper page
- van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R et al (2016) In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. NPJ Schizophr 2:16031 · DOI · Paper page
- Di Biase MA, Zalesky A, O’Keefe G, Laskaris L, Baune BT, Weickert CS et al (2017) PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia. Transl Psychiatry 7:e1225 · DOI
- Holmes SE, Hinz R, Drake RJ, Gregory CJ, Conen S, Matthews JC et al (2016) In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study. Mol Psychiatry 21:1672–1679 · DOI
- Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD et al (2018) Positron emission tomography studies of the glial cell marker translocator protein in patients with psychosis: a meta-analysis using individual participant data. Biol Psychiatry 84:433–442 · DOI · Paper page
- Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M et al (2012) Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 13:293–307 · DOI · Paper page
- Roberts RC (2017) Postmortem studies on mitochondria in schizophrenia. Schizophr Res 187:17–25 · DOI
- Somerville SM, Conley RR, Roberts RC (2011) Mitochondria in the striatum of subjects with schizophrenia. World J Biol Psychiatry 12:48–56 · DOI
- Nitta M, Kishimoto T, Müller N, Weiser M, Davidson M, Kane JM et al (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39:1230–1241 · DOI · Paper page
- Nozaki K, Ito H, Ohgidani M, Yamawaki Y, Sahin EH, Kitajima T et al (2020) Antidepressant effect of the translocator protein antagonist ONO-2952 on mouse behaviors under chronic social defeat stress. Neuropharmacology 162 · DOI
Cited by
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Liu, Y.-D., Chang, Y.-H., Xie, X.-T., Wang, X.-Y., Ma, H.-Y., Liu, M.-C., & Zhang, H.-M.
- Venue
- Molecular Neurobiology
- Published
- 2025-07-04
- Volume
- 62
- Issue
- 12
- Pages
- 15318-15335
- ISSN
- 0893-7648
- 1559-1182
- Cited by
- 27
- References
- 21
- Language
- en
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation. https://app.cochat.ai/papers/10.1007/s12035-025-05177-w
- The paper
- Liu, Y.-D., Chang, Y.-H., Xie, X.-T., Wang, X.-Y., Ma, H.-Y., Liu, M.-C., & Zhang, H.-M. (2025). PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05177-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.